KB Home Common Stock (KBH)
StalwartFairStock Score: 58/100 — STEADY
Key Financials
| Current Price | $45.07 |
| Market Cap | $3.5B |
| P/E Ratio | 8.7 |
| ROE | 8.87% |
| Dividend Yield | 1.92% |
| Sector | Consumer Cyclical |
Strengths
- Generates $427 million in annual free cash flow (12.2% yield on market cap)
Concerns
- Revenue declining at 22.6% year-over-year signals potential demand weakness or market share loss
- Weak Piotroski F-Score of 2/9 suggests deteriorating financial quality across multiple dimensions
AI Analysis
KB Home Common Stock is a small-cap consumer cyclical company valued at $3.5 billion. The business generates $5.9 billion in annual revenue with a 0.6% net margin and $427 million in free cash flow. From a quality standpoint, KB shows weak Piotroski F-Score of 2/9 signaling deteriorating fundamentals and Altman Z-Score of 2.6 in the grey zone. On valuation, the stock is attractively valued at 10.8x earnings, with offers a 34% margin of safety vs Graham Number of $85. Growth dynamics show revenue growing at -22.6% and profit growth of -69.5%. The 1.8% dividend yield adds an income component for patient holders. Our composite FairStock Score of 58/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
Improving fundamentals and sector tailwinds could drive meaningful earnings growth, compressing the effective multiple for patient investors. With $427 million in annual free cash flow (12.2% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the consumer cyclical space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer